Biomarker for identification of melanoma tumor cells

A technology for melanoma and cells, which is applied in antineoplastic drugs, biological testing, biomaterial analysis, etc., and can solve the problems of accurately identifying the longitudinal growth and metastasis process of melanoma

Inactive Publication Date: 2012-09-12
THE JOHN HOPKINS UNIV SCHOOL OF MEDICINE
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, many patients with thicker melanomas do not metastasize, while others with thinner tumors die early from their disease
Despite numerous research investigations to date, there are still insufficient methods to accurately identify the vertical growth and metastatic progression of melanoma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biomarker for identification of melanoma tumor cells
  • Biomarker for identification of melanoma tumor cells
  • Biomarker for identification of melanoma tumor cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] Example 1 Observation of melanoma endothelial cell communication in vitro

[0068] The interaction of tumor cells with adjacent endothelial cells is critical for tumor cell survival and metastasis. Melanoma is notorious for its ability to metastasize at a relatively early stage of development. Its aggressive behavior relies at least in part on the interaction between tumor cells and their surrounding stromal tissue. Neuropilin-2 (NRP2), a cell surface involved in angiogenesis and axon guidance, using a prolonged heterotypic cell co-culture system as a model for tumor-stromal cell interactions that occur during metastasis in vivo receptor, a gene thought to be highly upregulated in melanoma cells during their interaction with endothelial cells.

[0069] Three different in vitro melanoma-endothelial cell two-dimensional co-culture systems were used to identify molecular determinants of melanoma-endothelial cell communication ( Figure 1A ). These systems are designed t...

Embodiment 2

[0081] Example 2 Different gene expression during melanoma-endothelial cell communication

[0082] Among co-culture methods, random mixing methods are particularly advantageous for large-scale analysis of changes in the genetic composition of co-cultured cells due to the similar relative numbers and extensive interfaces between heterogeneous cells, which make most The cells may be involved in cell-to-cell, endothelial and melanoma cell communication. Therefore, gene expression profiles of sorted cells were determined using a random mixing approach followed by sorting of heterotypic cells based on cell type-specific fluorescent markers.

[0083] To define the molecular pathways governing melanoma-HUVEC communication, the formation of gene expression profiles of GFP-1205Lu and RFP-HUVEC alone or in mixed cultures for 48 h was performed ( Figure 2A ). Microarray analysis was performed as previously described [5] . Microsoft EXCEL generated a spreadsheet including the express...

Embodiment 3

[0091] Example 3. NRP2 is upregulated during melanoma-endothelial communication and expressed in metastatic melanoma cells

[0092] NRPs are transmembrane glycoproteins that regulate the nervous and vascular systems[17-19] development. They function as co-receptors interacting with the vascular endothelial growth factor (VEGF) receptor and plexin, and bind two receptors known to have different functions: type 3 semaphorin, related to the axis synapse guidance; and members of the VEGF family known to promote angiogenesis. Recent studies have shown that blocking the function of NRP2 can inhibit the metastasis of tumor cells by affecting the metastasis of lymphatic endothelial cells and the formation of tumor-associated lymphocytes. [20] . NRPs are also involved in tumorigenesis as they are expressed in various cancers [17,21-27] superior. Furthermore, NRP2 has recently been shown to regulate processes critical to angiogenesis and melanoma metastasis in vivo [30] , but its r...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention relates to use of neuropilin-2 as a novel biomarker and therapeutic target for melanoma. The presence of neuropilin-2 can be used as a biomarker for diagnosing and detecting individuals suffering from or at risk for developing melanoma. Also described are methods of using neuropilin-2 to capture circulating melanoma cells. The present invention further relates to methods of treating an individual suffering from or at risk for developing melanoma with an agent that inhibits the activity of neuropilin-2.

Description

[0001] This application claims the benefit of the filing dates of Provisional Patent Application Nos. 61 / 251123, filed October 13, 2009, and 61 / 257074, filed November 2, 2009, both of which are incorporated herein in their entirety by refer to. technical field [0002] The present invention relates to the application of cell surface receptor neuropilin-2 (neuropilin-2, NRP-2, a transmembrane protein) as a new biomarker in the detection of melanoma tumor cells, and its use as a new therapeutic target in melanoma Application in tumor treatment. Background technique [0003] In the United States, the incidence of melanoma is one of the fastest rising rates of all cancers, with a current lifetime risk of 1 in 58. In the United States, it is estimated that more than 60,000 patients will be diagnosed with melanoma in 2008, and more than 8,000 will die. There are currently no effective systemic treatments for advanced disease, and the average life expectancy of patients with adva...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): G01N33/574G01N33/532G01N33/68
CPCG01N33/5743G01N2333/70596A61P17/00A61P35/00
Inventor罗达·M·阿拉尼瓦海·F·莫里亚蒂
OwnerTHE JOHN HOPKINS UNIV SCHOOL OF MEDICINE